验证数据展示
经过测试的应用
Positive WB detected in | SGC-7901 cells, Jurkat cells |
Positive IHC detected in | human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 2 publications below |
IHC | See 2 publications below |
产品信息
11151-1-AP targets MYEOV in WB, IHC, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IHC, ELISA Application Description |
文献引用应用 | WB, IHC |
经测试反应性 | human |
文献引用反应性 | human |
免疫原 | MYEOV fusion protein Ag1498 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas) |
别名 | MYEOV, OCIM, Oncogene in multiple myeloma |
计算分子量 | 33 kDa |
观测分子量 | 55-60 kDa |
GenBank蛋白编号 | BC011815 |
基因名称 | MYEOV |
Gene ID (NCBI) | 26579 |
RRID | AB_671520 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q96EZ4 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
MYEOV, also named as OCIM, was originally isolated by the application of the NIH/3T3 tumorigenicity assay with DNA from a gastric carcinoma. It is a prognostic factor for patients with multiple myeloma, in part through a role of MYEOV in the control of MMC proliferation. MYEOV is a candidate oncogene activated in the amplification core located proximal toCCND1. The observed MW of this protein is 55 kDa(PMID: 20854874 ).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for MYEOV antibody 11151-1-AP | Download protocol |
IHC protocol for MYEOV antibody 11151-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Cell Oncol (Dordr) Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer | ||
Cell Cycle Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma. | ||
Cancers (Basel) Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer |